Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
Recruiting now · Not applicable
Conditions studied: Aortic Stenosis Treated With TAVI, Aortic Diseases
In brief
The objective of this study is to compare the safety and effectiveness of the F2 Cerebral Protection System (CPS) to a standard of care control group in patients undergoing Transcatheter Aortic Valve Replacement (TF TAVR)
Key facts
- Study ID
- NCT06689839
- Run by
- EnCompass Technologies, Inc.
- People needed
- 500
- Starts
- 2025-09-09
- Expected to finish
- 2027-01-01
- Last updated by the study team
- 2025-11-20
Who can join
Age: 50 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Monash Health Public — Clayton, Victoria, Australia (enrolling)
- St. Vincent Hospital — Indianappolis, Indiana, United States (enrolling)
- Henry Ford Hospital — Detroit, Michigan, United States (enrolling)
- St. Lukes Hospital Of Kansas City — Kansas City, Missouri, United States (enrolling)
- Cumc/Nyph — New York, New York, United States (enrolling)
- Cleveland Clinic Foundation — Cleveland, Ohio, United States (enrolling)
- Ohio Health Research Institute (aka Riverside Methodist Hospital) — Columbus, Ohio, United States
- University of Virginia Medical Center — Charlottesville, Virginia, United States
- St Andrews War Memorial Hospital — Spring Hill, Queensland, Australia
- NCH Baker Hospital-Naples Heart Institute — Naples, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.